Mater Misericordiae University Hospital — Clinical Trial Site

114 Registered trials

50 Currently recruiting

Organisation

Mater Misericordiae University Hospital

Location

Dublin 7, Ireland

Identifier

ORG-100028391

Address

Eccles Street, Ireland

Departments

#192: Pulmonology
3901: Haematology
3901: Oncology
3901: START Dublin
3902:Clinical Trials Research Unit
Cancer Directorate Radiation Oncology
Cardiology
Cardiovascular Research Institute
Catherine McAuley Centre
Catherine McAuley Research Centre
Clinical Trials Research Unit
Clinical Trials Unit
Department of Infectious Diseases
Department of Medical Oncology
Department of Oncology
Department of Radiation Oncology
Dept Of ID
Dermatology
Gynaecologic Oncology
Gynaecological Oncology
Haematologist
Haematology
Haematology/Oncology Clinical Trial Research Unit
Hematology
Infectious Disease
Infectious Diseases
Institute For Cancer Research
Intensive Care Unit
Medical Oncology
n/a
NA
Neurology
Neurology / Stroke
nfectious diseases and genitourinary medicine
Oncology
Oncology Department
Oncology/Haematology Clinical Trials Research Unit
Pain Medicine
Pathology
Respiratory
Respiratory Department
Respiratory Medicine
START Dublin
Stroke Dept
Trials Unit

Clinical trials at this site (114)

Search interface

Extension Study of ACT-EARLY Pending

2024-513676-18-00 Transthyretin Amyloidosis 5
Evaluating a Personalized Treatment Strategy for Young Women with Early Breast Cancer Pending

2024-519655-28-00 Premenopausal patients with high-risk HR-positive/HER2- 5
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH). Pending

2024-520218-23-00 Pulmonary Arterial Hypertension 10
STAMPEDE2: A randomised controlled platform trial testing treatments in metastatic hormone sensitive prostate cancer Pending

2025-522145-21-00 Metastatic hormone sensitive prostate cancer 5
A phase 3 trial comparing elritercept versus epoetin alfa for treatment of anemia due to lower-risk MDS in ESA-naïve adults who require RBC … Pending

2025-523544-12-00 Myelodysplastic neoplasms/syndromes (MDS) 5
A clinical trial studying the effect of Tirzepatide in women living with endometrial cancer Pending

2025-523877-40-00 Endometrial adenocarcinoma 4
MAVRiC studies 2L treatment with AV in patients with CLL/SLL who have relapsed after a course of BTKi + BCL2i combination, with and without … Recruiting

2024-518858-17-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 4 2026-05-22
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01) Recruiting

2025-520466-22-00 Advanced Platinum-resistant Epithelial Ovarian Cancer 5 2026-04-29
Phase 1 trial of valemetostat and darolutamide in mCRPC Recruiting

2025-522512-16-00 Metastatic Castration Resistant Prostate Cancer (mCRPC) 3 2026-04-23
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors Recruiting

2025-523686-15-00 Advanced or Metastatic Solid Tumors 1 2026-04-08
A study to investigate the effect of adding bleximenib to standard-of-care treatment with intensive chemotherapy in patients with a specific… Recruiting

2025-522767-15-00 Acute Myeloid Leukemia 5 2026-01-27
A clinical study of sacituzumab tirumotecan for cervical cancer (MK-2870-036) Recruiting

2025-521514-26-00 Persistent, Recurrent, or Newly Diagnosed Metastatic Ce 5 2026-01-26
A Phase III Randomised, Open Label Trial of an Intradermal or Subcutaneous booster dose of MVA-BN Vaccine to Investigate MPXV Immunogenicity… Recruiting

2024-518007-22-00 Prevention of monkeypox (mpox) infection 5 2025-12-05
A study to investigate the effect of adding venetoclax to treatment with ivosidenib and azacitidine in patients with acute myeloid leukemia … Recruiting

2024-512753-24-00 Acute Myeloid Leukemia (AML) 5 2025-08-05
BOLD-100 in Combination with FOLFOX for the Treatment of Advanced Solid Tumours Recruiting

2024-517500-11-00 Colorectal Cancer 7 2025-07-15
A study investigating the effect of adding revumenib to treatment with venetoclax + azacitidine in patients with acute myeloid leukemia (AML… Recruiting

2024-512733-32-00 Acute Myeloid Leukemia (AML) 5 2025-03-31
A study to assess the Efficacy and Safety of Efgartigimod IV in Adult Participants with Primary Immune Thrombocytopenia Recruiting

2024-515451-38-00 Primary Immune thrombocytopenia (ITP) 5 2025-02-27
Clinical trial of MDNA11 (investigational drug) administered alone or in combination with pembrolizumab (immune checkpoint inhibitor) in Pat… Recruiting

2023-507536-21-00 Advanced Solid Tumors 7 2024-10-04
Study BT8009-230 in Subjects with Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) Recruiting

2023-504231-41-01 Locally advanced or metastatic urothelial cancer 10 2024-10-02
Clinical trial that compares MK-2870 with or without pembrolizumab to chemotherapy in people with breast cancer that cannot be surgically re… Recruiting

2023-504918-29-00 Hormone receptor positive breast cancer 5 2024-08-22
Disitamab Vedotin with Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 Recruiting

2022-501105-12-00 Urothelial Carcinoma 5 2024-07-15
TENECTEPLASE IN CENTRAL RETINAL ARTERY OCCLUSION STUDY (TenCRAOS): A Prospective, randomised-controlled, double-dummy, double-blind phase 3 … Recruiting

2024-517606-29-00 Central retinal artery occlusion 5 2020-10-30
Study of STK-012 Alone and with Other Treatments in Patients with Advanced Lung Cancer and Other Cancers Recruiting

2025-522632-14-00 Non-small cell lung cancer (NSCLC) 4 2026-05-11
Phase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients with Advanced Solid Tumors Recruiting

2025-524111-37-00 advanced solid tumors 7 2026-04-28